Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2021 | Lifileucel, a novel TIL in melanoma

Sajeve S. Thomas • 27 May 2021
ASCO 2021
Melanoma Skin Cancer

Sajeve S. Thomas, MD, Orlando Health UF Health, Orlando, FL, introduces lifileucel, a tumor-infiltrating lymphocyte (TIL), derived from a patient’s own tumor. This interview was conducted at the American Society of Clinical Oncology (ASCO) 2021 Virtual Meeting.

More from Sajeve S. Thomas

1:09
Progress in treatment approaches for patients with melanoma
Sajeve S. Thomas • 27 May 2021

Related Videos

1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
2:12
Novel immunotherapeutic approaches to treat patients with melanoma
Christoffer Gebhardt • 9 Apr 2024
1:22
INTerpath-001: individualized neoantigen vaccines with pembrolizumab in melanoma
Christoffer Gebhardt • 9 Apr 2024
2:15
Reducing the need for sentinel node biopsies in cutaneous melanoma
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals